Clinical Trials on Metabolic Dysfunction-associated Fatty Liver Disease in United States
Total 1239 results
-
EchosensCompletedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Boston Children's HospitalCompletedHepatic SteatosisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Washington University School of MedicineCompleted
-
PfizerCompletedNon-alcoholic SteatohepatitisUnited States, Canada
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNonalcoholic SteatohepatitisUnited States
-
National Human Genome Research Institute (NHGRI)TerminatedLiver Cirrhosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steato-HepatitisUnited States
-
University of California, San DiegoCompletedNon Alcoholic SteatohepatitisUnited States
-
Imperial College LondonCompletedNon-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Boehringer IngelheimCompletedNon-alcoholic Fatty Liver DiseaseUnited States, Spain, United Kingdom, Belgium, Canada, Germany, Netherlands, France, Ireland
-
Methodist Health SystemWithdrawnNon-alcoholic Steatohepatitis (NASH)United States
-
Mayo ClinicRecruiting
-
National Center for Complementary and Integrative...TerminatedLiver Diseases | Diabetes Mellitus | Fatty Liver | Hepatic SteatosisUnited States
-
University of PittsburghTerminatedNonalcoholic Steatohepatitis | Post Liver Transplantation Weight Gain | Post Liver Transplantation ObesityUnited States
-
University of Kansas Medical CenterGilead SciencesRecruiting
-
University of Illinois at ChicagoTerminatedNonalcoholic Steatohepatitis (NASH) | Hepatic SteatosisUnited States
-
AstraZenecaActive, not recruitingNon-alcoholic Steatohepatitis (NASH)United States
-
University of Colorado, DenverCompletedNon-Alcoholic SteatohepatitisUnited States
-
University of MinnesotaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Madaus IncUniversity of Pennsylvania; Beth Israel Deaconess Medical Center; University... and other collaboratorsCompletedNon-alcoholic SteatohepatitisUnited States
-
Axcella Health, IncCompleted
-
AstraZenecaParexelCompletedNon-alcoholic Steatohepatitis (NASH)United States
-
Corcept TherapeuticsRecruitingNon-alcoholic Steatohepatitis (NASH)United States
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
University of BirminghamNovo Nordisk A/S; Wellcome TrustCompletedNonalcoholic SteatohepatitisUnited Kingdom
-
Virginia Commonwealth UniversityObesity Treatment FoundationCompletedObesity | Fatty Liver | Ketogenic DietingUnited States
-
Hepanova Inc.UnknownNon-Alcoholic Steatohepatitis (NASH)United States
-
Pinnacle Clinical Research, PLLCCompletedFatty Liver | Fibrosis, Liver | Compensated Cirrhosis | Non-alcoholic SteatohepatitisUnited States
-
Fibronostics USA, IncCompletedNon-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Liver Inflammation | Liver Fibroses | Liver SteatosesUnited States
-
Target PharmaSolutions, Inc.RecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States, Germany, Spain
-
AlbireoCompleted
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American...CompletedFatty Liver | Hepatic SteatosisUnited States
-
VSL PharmaceuticalsTerminated
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
HepQuant, LLCTerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
CytoDyn, Inc.Amarex Clinical ResearchCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India, Israel, Switzerland, United Kingdom
-
Galectin Therapeutics Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Mayo ClinicRecruitingObesity, Morbid | Chronic Inflammation | NASH - Nonalcoholic SteatohepatitisUnited States
-
Alnylam PharmaceuticalsTerminatedNonalcoholic Steatohepatitis | NASHUnited States, Bulgaria, United Kingdom, Belgium, Turkey
-
PfizerCompletedNon-Alcoholic Steatohepatitis(NASH)United States
-
89bio, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Massachusetts General HospitalNational Institutes of Health (NIH)WithdrawnNon-alcoholic Fatty Liver DiseaseUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
Novartis PharmaceuticalsTerminatedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Germany, Argentina
-
University of California, San DiegoRecruitingLiver DiseaseUnited States
-
University of BathAbertay UniversityCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited Kingdom